Display options
Share it on

Toxicol Res. 2016 Jan;32(1):47-56. doi: 10.5487/TR.2016.32.1.047. Epub 2016 Jan 31.

Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury.

Toxicological research

Ji Hyun Cheon, Sun Young Kim, Ji Yeon Son, Ye Rim Kang, Ji Hye An, Ji Hoon Kwon, Ho Sub Song, Aree Moon, Byung Mu Lee, Hyung Sik Kim

Affiliations

  1. School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
  2. College of Pharmacy, Duksung Women's University, Seoul, Korea.

PMID: 26977258 PMCID: PMC4780241 DOI: 10.5487/TR.2016.32.1.047

Abstract

The identification of biomarkers for the early detection of acute kidney injury (AKI) is clinically important. Acute kidney injury (AKI) in critically ill patients is closely associated with increased morbidity and mortality. Conventional biomarkers, such as serum creatinine (SCr) and blood urea nitrogen (BUN), are frequently used to diagnose AKI. However, these biomarkers increase only after significant structural damage has occurred. Recent efforts have focused on identification and validation of new noninvasive biomarkers for the early detection of AKI, prior to extensive structural damage. Furthermore, AKI biomarkers can provide valuable insight into the molecular mechanisms of this complex and heterogeneous disease. Our previous study suggested that pyruvate kinase M2 (PKM2), which is excreted in the urine, is a sensitive biomarker for nephrotoxicity. To appropriately and optimally utilize PKM2 as a biomarker for AKI requires its complete characterization. This review highlights the major studies that have addressed the diagnostic and prognostic predictive power of biomarkers for AKI and assesses the potential usage of PKM2 as an early biomarker for AKI. We summarize the current state of knowledge regarding the role of biomarkers and the molecular and cellular mechanisms of AKI. This review will elucidate the biological basis of specific biomarkers that will contribute to improving the early detection and diagnosis of AKI.

Keywords: Acute kidney injury; Biomarker; Pyruvate kinase M2

References

  1. Int Urol Nephrol. 2001;33(4):673-6 - PubMed
  2. Mol Cell. 2002 Nov;10(5):1045-56 - PubMed
  3. Toxicol Pathol. 2010 Oct;38(6):943-56 - PubMed
  4. Matrix. 1993 Mar;13(2):113-23 - PubMed
  5. Oman Med J. 2014 Jul;29(4):285-8 - PubMed
  6. Kidney Int. 1998 Dec;54(6):1817-31 - PubMed
  7. Blood Purif. 2003;21(3):258-70 - PubMed
  8. Kidney Int. 2001 Nov;60(5):1645-57 - PubMed
  9. Toxicol Sci. 2008 Jan;101(1):159-70 - PubMed
  10. Crit Care. 2007;11(2):R31 - PubMed
  11. Vox Sang. 1980 Jun;38(6):323-7 - PubMed
  12. Nat Rev Nephrol. 2011 Apr;7(4):201-8 - PubMed
  13. BJU Int. 2013 Aug;112(4):517-25 - PubMed
  14. Lancet. 2005 Apr 2-8;365(9466):1231-8 - PubMed
  15. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):426-30 - PubMed
  16. Kidney Int. 2008 Oct;74(8):1059-69 - PubMed
  17. N Engl J Med. 1996 May 30;334(22):1448-60 - PubMed
  18. Nat Biotechnol. 2010 May;28(5):478-85 - PubMed
  19. Am J Transplant. 2006 Apr;6(4):652-8 - PubMed
  20. Am J Transplant. 2005 Apr;5(4 Pt 1):729-38 - PubMed
  21. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819-23 - PubMed
  22. Biochem J. 2004 Aug 15;382(Pt 1):157-68 - PubMed
  23. Clin J Am Soc Nephrol. 2008 May;3(3):665-73 - PubMed
  24. J Biol Chem. 1998 Feb 13;273(7):4135-42 - PubMed
  25. Kidney Int. 2002 Jul;62(1):237-44 - PubMed
  26. Am J Physiol Renal Physiol. 2008 Nov;295(5):F1414-21 - PubMed
  27. Nat Biotechnol. 2010 May;28(5):470-7 - PubMed
  28. Toxicol Sci. 2014 Aug 1;140(2):247-58 - PubMed
  29. Nature. 2008 Mar 13;452(7184):230-3 - PubMed
  30. J Clin Pathol. 1989 Jun;42(6):624-8 - PubMed
  31. Am J Med. 2005 Aug;118(8):827-32 - PubMed
  32. Clin Lab Med. 1988 Sep;8(3):507-26 - PubMed
  33. Scand J Rheumatol. 2005;34(1):34-9 - PubMed
  34. Diabetes Care. 2009 Oct;32(10):1833-8 - PubMed
  35. Toxicol Sci. 2007 Oct;99(2):637-48 - PubMed
  36. PLoS One. 2015 Jul 06;10(7):e0132695 - PubMed
  37. Kidney Int. 1985 Jun;27(6):928-37 - PubMed
  38. Compr Physiol. 2012 Apr;2(2):1303-53 - PubMed
  39. Kidney Int. 2013 Oct;84(4):810-7 - PubMed
  40. Kidney Int. 2004 Sep;66(3):1115-22 - PubMed
  41. Crit Care. 2005 Apr;9(2):R139-43 - PubMed
  42. Clin Chem. 2002 Sep;48(9):1604-5 - PubMed
  43. Mol Metab. 2014 Mar 22;3(4):384-93 - PubMed
  44. Asia Pac J Clin Nutr. 2014;23(1):174-80 - PubMed
  45. Ren Fail. 2008;30(9):904-13 - PubMed
  46. Kidney Int. 2006 Jul;70(1):199-203 - PubMed
  47. J Pharm Biomed Anal. 2001 Mar;24(5-6):835-42 - PubMed
  48. Clin J Am Soc Nephrol. 2006 Nov;1(6):1314-9 - PubMed
  49. J Cell Biol. 1988 Feb;106(2):441-50 - PubMed
  50. Nat Rev Nephrol. 2011 Oct 25;8(1):22-33 - PubMed
  51. Nephron. 2000 Jun;85(2):120-6 - PubMed
  52. J Exp Med. 1989 Jul 1;170(1):145-61 - PubMed
  53. Biochem Soc Trans. 1990 Apr;18(2):193-6 - PubMed
  54. J Bioenerg Biomembr. 2007 Jun;39(3):223-9 - PubMed
  55. Kidney Int. 2005 Mar;67(3):886-96 - PubMed
  56. Diagn Pathol. 2012 Oct 12;7:141 - PubMed
  57. Blood. 1995 Feb 1;85(3):812-7 - PubMed
  58. Nephrol Dial Transplant. 2009 Nov;24(11):3265-8 - PubMed
  59. Mol Biosyst. 2016 Jan;12(1):133-44 - PubMed
  60. Annu Rev Pharmacol Toxicol. 2008;48:463-93 - PubMed
  61. Pediatr Nephrol. 2015 Apr;30(4):677-85 - PubMed
  62. Kidney Int. 2015 Oct;88(4):691-8 - PubMed
  63. J Am Soc Nephrol. 2014 May;25(5):998-1012 - PubMed
  64. J Pathol. 2007 Jun;212(2):209-17 - PubMed
  65. Urology. 2012 Aug;80(2):267-72 - PubMed
  66. Kidney Int. 2008 Apr;73(7):863-9 - PubMed
  67. Am J Transplant. 2008 Apr;8(4):753-60 - PubMed
  68. J Toxicol Environ Health A. 2014;77(22-24):1384-98 - PubMed
  69. Mol Biol Cell. 1992 Oct;3(10):1169-80 - PubMed
  70. J Cyst Fibros. 2009 Jan;8(1):19-25 - PubMed
  71. J Urol. 2013 Jul;190(1):159-64 - PubMed
  72. Biol Pharm Bull. 1999 Oct;22(10):1127-30 - PubMed
  73. Kidney Int. 2011 Aug;80(4):338-47 - PubMed
  74. Cancer. 1991 Mar 15;67(6):1608-13 - PubMed
  75. Anticancer Res. 2007 Nov-Dec;27(6B):3963-71 - PubMed
  76. Nature. 1995 Nov 2;378(6552):88-91 - PubMed

Publication Types